K. Rezvani

Immunology · 2017–2022

A researcher in the Science corpus: 6 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom K. Rezvani trusts

Their strongest outbound trust, strongest first, inferred from their citations.

  1. L. Lanier (in Immunology)

Papers from K. Rezvani's perspective

Ordered by how strongly the researchers K. Rezvani trusts endorse each paper. Same corpus, a different order for every researcher.

  1. T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial (The Lancet)
  2. Current concepts in the diagnosis and management of cytokine release syndrome. (Blood)
  3. Adoptive-cell-transfer therapy for the treatment of patients with cancer (Nature Reviews. Cancer)
  4. Neoadjuvant versus adjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma (Nature Medicine)
  5. Presence of B cells in tertiary lymphoid structures is associated with a protective immunity in patients with lung cancer. (American Journal of Respiratory and Critical Care Medicine)
  6. Tertiary lymphoid structures in the era of cancer immunotherapy (Nature Reviews. Cancer)
  7. Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression (Genome Biology)
  8. RNA-Seq workflow: gene-level exploratory analysis and differential expression (F1000Research)
  9. Effectiveness of Donor Natural Killer Cell Alloreactivity in Mismatched Hematopoietic Transplants (Science)
  10. Adaptive Immune Features of Natural Killer Cells (Nature)

Their papers